Olea Sensor Networks CEO to Speak at Telehealth Secrets 2019

RENO, Nev., Sept. 26, 2019 /PRNewswire/ — Frank Morese, CEO and CTO of Olea Sensor Networks, will speak at this year’s Telehealth Secrets Conference in Silicon Valley, October 2-4 addressing the benefits of machine learning diagnostic technologies for medical applications. His topic, Reviving the Family Doctor with AI Technology, will discuss how artificial intelligence is able to mitigate the loss of personalization experienced in today’s medical relationships.   

Olea Sensor Networks, as an industry leader in intelligent sensors and analytic software for sensor network-based systems, will also be on hand on the exhibit floor to demo the OSN Quadcorder for remote health monitoring applications powered by the intelligent software and software analytics capabilities of OleaSense technology. This powerful platform for vital sign monitoring is now available in a new, low cost version, the OleaSense-LX, compatible with all Linux platforms including Raspberry Pi. Unlike claims of some vital sign sensing approaches today, OleaSense can produce clinically accurate vital signs collection and biometric authentication with absolutely no contact with the user. Clinical accuracy has been verified under multiple, strictly monitored, IRB studies.

VSee, Inc., organizers of the Telehealth Secrets conference, anticipate more than 500 attendees this year with past speakers including many health industry leaders, innovators and transformers. This years’ conference promises to inspire and inform. Tickets may be obtained on their website at https://vsee.com/#register.

About Olea

Olea Sensor Networks, incorporated in 2011, develops intelligent sensors and analytic software for advanced “Internet of Things” (IoT) service solutions including a wide variety of applications. Olea specializes in developing non-intrusive sensing technologies and wireless sensor networks including OleaSense, vital sign biometrics technology for advanced safety systems and autonomous driving sensing applications and OleaVision, for Life Presence Detection. Olea technologies and development platforms are offered for non-clinical research and development use, including field trials and testing. Olea is located in Reno, Nevada. For more information go to www.oleasys.com. Follow us on Twitter @OleaSys.

Olea, Olea Sensor Networks, Olea HeartSensor, Olea HeartSignature, OleaSense, OleaVision, BalancedSense, RespiroTrack, IoT Intelligent Partitioning Architecture, OSN Quadcorder, DrowseAlert are trademarks of Olea Systems, Incorporated. Other trademarks (registered or otherwise), names and brands may be claimed as property of Olea Systems, Incorporated or by others.

Contact:
Andrea Morese
(775) 636-7680 
223549@email4pr.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/olea-sensor-networks-ceo-to-speak-at-telehealth-secrets-2019-300925542.html

SOURCE Olea Sensor Networks

Staff

Recent Posts

Creative Medical Technology Holdings Provides Corporate Update

PHOENIX--(BUSINESS WIRE)--Creative Medical Technology Holdings, Inc., (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a…

18 mins ago

GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist

Prostate Volume Assist (PVA) is the company’s proprietary urology-based artificial intelligence (AI) software feature designed…

20 mins ago

Sutter Health Partners with Abridge on Generative AI Solution to Improve Patient, Physician Experience

PITTSBURGH & SACRAMENTO, Calif.--(BUSINESS WIRE)--Today, Abridge and Sutter Health announced they will make Abridge’s generative…

21 mins ago

Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting

Presentations Will Feature Studies Evaluating TENEO™ Excimer Laser Platform, MIEBO® (Perfluorohexyloctane Ophthalmic Solution) and enVista®…

22 mins ago

Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program

Blackstone Life Sciences to invest up to $750 million to support innovative mRNA technologyNEW YORK--(BUSINESS…

23 mins ago

Male Contraceptive Initiative Marks Women’s History Month With Investment in Birth Control Pill for Men

Phase 1a study of first hormone-free male pill completes enrollmentDURHAM, NC / ACCESSWIRE / March…

24 mins ago